Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0414 per EA under NDC 68645055954. Its NADAC has been published 488 times since May 31, 2017.
FDA first approved this application on Mar 27, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Legacy Pharmaceutical Packaging, LLCNDC
68645055954
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078216FDA Approved
3/27/2007
TE Code
AB
On Market Since
10/18/2007
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 488 times since May 31, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0414 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0347 (Oct 23, 2019) |
| 52-week high | $0.0464 |
| 52-week low | $0.0414 |
| Median price | $0.0396 |
| Average price | $0.0404 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 488 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Legacy Pharmaceutical Packaging, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Citalopram Hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0414 per EA (NDC 68645055954), effective Sep 30, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 488 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since May 31, 2017, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0396 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 68645055954) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.